Octovorko is one of the largest private pharmaceutical manufacturers in the Middle East, founded in 1972 by the late Dr. Mostafa Naraghi. The company specializes in the production of over 330 pharmaceutical products across 15 therapeutic areas. Its diverse portfolio includes medications for infectious diseases, respiratory issues, gastrointestinal disorders, neurology, psychiatry, oncology, diabetes, and more.

The company boasts state-of-the-art production facilities that enable it to manufacture billions of tablets, capsules, and injectable medications annually. Octovorko has also made significant contributions to the response to COVID-19, including developing vaccines and essential medications.

With a strong commitment to social responsibility, Octovorko actively participates in community development initiatives, supporting education and healthcare for underprivileged children in Iran and neighboring countries. This focus on innovation and technology has established Octovorko as a leader in the pharmaceutical sector, dedicated to improving health outcomes and meeting the needs of its customers both domestically and internationally.